Elanco Animal Health Incorporated (ELAN)
Company Info
US28414H1032
28414H103
Sep 20, 2018
Highlights
$5.56B
$0.40
28.13
1.84
$3.42B
$1.65B
$1.28B
$10.77 - $18.80
$16.92
5.38%
3.63
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Elanco Animal Health Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Elanco Animal Health Incorporated had a return of -7.10% year-to-date (YTD) and -30.77% in the last 12 months.
ELAN
-7.10%
-6.41%
-24.09%
-30.77%
-17.84%
N/A
^GSPC (Benchmark)
3.96%
1.97%
9.03%
22.16%
12.60%
11.26%
Monthly Returns
The table below presents the monthly returns of ELAN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.66% | -7.10% | |||||||||||
| 2024 | -1.07% | 7.80% | 2.45% | -19.16% | 34.35% | -18.38% | -9.63% | 18.63% | -5.04% | -13.96% | 4.51% | -8.33% | -18.72% |
| 2023 | 12.36% | -16.46% | -18.05% | 0.74% | -13.94% | 23.44% | 19.98% | 1.08% | -7.87% | -21.62% | 33.71% | 26.49% | 21.93% |
| 2022 | -8.25% | 9.10% | -8.17% | -2.99% | -6.36% | -17.17% | 3.21% | -25.32% | -17.98% | 6.29% | -2.43% | -5.05% | -56.94% |
| 2021 | -5.35% | 13.19% | -10.38% | 7.67% | 13.47% | -3.59% | 5.13% | -8.47% | -4.46% | 3.10% | -12.59% | -1.25% | -7.47% |
| 2020 | 4.92% | -11.33% | -18.28% | 10.36% | -13.35% | 0.19% | 10.16% | 22.98% | -3.89% | 11.03% | -1.35% | 0.26% | 4.14% |
| 2019 | -7.45% | 3.63% | 6.05% | -1.78% | -0.70% | 8.06% | -2.49% | -21.06% | 2.19% | 1.62% | 2.55% | 6.28% | -6.60% |
| 2018 | -3.08% | -12.64% | 9.61% | -5.63% | -12.42% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ELAN is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Elanco Animal Health Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Elanco Animal Health Incorporated was 78.00%, occurring on May 30, 2023. The portfolio has not yet recovered.
The current Elanco Animal Health Incorporated drawdown is 69.36%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78% | Aug 4, 2021 | 458 | May 30, 2023 | — | — | — |
| -53.91% | Sep 28, 2018 | 369 | Mar 18, 2020 | 340 | Jul 23, 2021 | 709 |
| -5.28% | Sep 21, 2018 | 1 | Sep 21, 2018 | 4 | Sep 27, 2018 | 5 |
| -1.89% | Jul 26, 2021 | 1 | Jul 26, 2021 | 2 | Jul 28, 2021 | 3 |
| -0.46% | Jul 29, 2021 | 2 | Jul 30, 2021 | 2 | Aug 3, 2021 | 4 |
Volatility
Volatility Chart
The current Elanco Animal Health Incorporated volatility is 9.25%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Elanco Animal Health Incorporated compared to its peers in the Drug Manufacturers - Specialty & Generic industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for ELAN in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a PE value of 28.1. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for ELAN in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, ELAN has a PEG value of 1.8. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Elanco Animal Health Incorporated.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |